Form 4 for ZNTL Zentalis Pharmaceuticals, Inc.
Accepted 2025-02-04 00:00:00 ET · period of report 2025-01-31 · accession 0001725160-25-000028 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-04 | 2025-01-31 | ZNTL | EASTLAND JULIA MARIE | CEO, Pres, Dir | P - Purchase | $1.73 | +28.5K | 28.5K | New | +$49.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-31 | P | A | 28,500 | $1.73 | 28,500 | D | — | — |